Imran Ahmad

Dr. Imran Ahmad is an Associate Clinical Professor at the Université de Montréal's Faculty of Medicine, Department of Medicine. He serves as Director of the Cellular Transplantation & Therapy Program and Clinical Research Unit at Hôpital Maisonneuve-Rosemont, a leading Canadian center in hematology and stem cell transplantation. His research focuses on allogeneic transplantation, graft-versus-host disease (GVHD), and improving outcomes for patients with hematologic malignancies. He is affiliated with the Centre de recherche de l'Hôpital Maisonneuve-Rosemont and holds chairs in Myeloma Research and Stem Cell Transplantation.

Education & Training:

• Doctorate in Medicine, Free University of Brussels (2002-2007)
• Fellowship in Hematopoietic Stem Cell Transplantation, University of Montreal (2007-2010)
• Masters in Epidemiology, McGill University (2011-2013)

Research Expertise: Dr. Ahmad's work emphasizes clinical research methodology and advancements in cellular therapies, particularly using UM171-expanded cord blood transplantation. His projects aim to enhance survival rates and quality of life through innovations in GVHD prevention and transplant conditioning regimens.

Awards:

• 2010: Highest Distinction in Hematology (Free University of Brussels)
• 2007: High Distinction in Internal Medicine (Free University of Brussels)

Grants & Clinical Trials: Leads trials evaluating bortezomib maintenance post-transplant and UM171-expanded cord blood grafts in high-risk myeloma patients. Collaborates on international studies assessing novel cellular therapies alongside traditional transplant approaches.

Labs & Teams: Member of the Hematopoietic Stem Cell Transplantation Clinical Research Unit and key contributor to the Myélome Canada research chair. Active in professional societies including the American Society for Transplantation & Cellular Therapy and European Haematology Association.